OBJECTIVES: To analyse the distribution, expression of chemokine receptors and ex vivo production of inflammatory cytokines by peripheral blood (PB) monocytes and DC in HIV-1+ individuals. DESIGN: Dendritic cells (DC) play an important role in the establishment and dissemination of HIV infection. DC interaction with HIV depends on expression of HIV receptors and co-receptors. Accumulating evidence supports the notion that DC functionality is impaired in HIV-1+ patients. METHODS: PB samples from 30 naive-treated HIV-1+ progressors were studied. Additionally, 10 adult healthy volunteers (AHV), seven Hepatitis C virus positive (HCV+)/HIV-1- patients and five long-term non-progressor HIV-1+ patients (HIV-1+LTNP) were included as controls. Flow cytometry immunophenotyping was used for the identification, enumeration and characterization of monocytes and DC. RESULTS: PB myeloid DC (mDC) and plasmacytoid DC (pDC) were significantly decreased in HIV-1+ progressors, while unaltered in HIV-1+LTNP. The expression of CXCR2 and CXCR4 and of CXCR4 and CCR5 were severely altered on PB mDC and pDC from HIV-1+ progressors, respectively. By contrast, both the expression of the chemokine receptors analysed and the numbers of CD16+ DC in HIV-1+ progressors were not different from AHV, while altered in HCV+/HIV-1- and HIV-1+LTNP. Furthermore, PB monocytes and DC from HIV-1+ progressors spontaneously produced inflammatory cytokines, in contrast with AHV. CONCLUSIONS: These results support the existence of a selective interaction between HIV-1 and both mDC and pDC, associated with HCV co-infection-independent spontaneous production of inflammatory cytokines, reflecting the occurrence of in vivo activation of the immune system, which might further contribute to the impaired DC functionality.
OBJECTIVES: To analyse the distribution, expression of chemokine receptors and ex vivo production of inflammatory cytokines by peripheral blood (PB) monocytes and DC in HIV-1+ individuals. DESIGN: Dendritic cells (DC) play an important role in the establishment and dissemination of HIV infection. DC interaction with HIV depends on expression of HIV receptors and co-receptors. Accumulating evidence supports the notion that DC functionality is impaired in HIV-1+ patients. METHODS: PB samples from 30 naive-treated HIV-1+ progressors were studied. Additionally, 10 adult healthy volunteers (AHV), seven Hepatitis C virus positive (HCV+)/HIV-1- patients and five long-term non-progressor HIV-1+ patients (HIV-1+LTNP) were included as controls. Flow cytometry immunophenotyping was used for the identification, enumeration and characterization of monocytes and DC. RESULTS: PB myeloid DC (mDC) and plasmacytoid DC (pDC) were significantly decreased in HIV-1+ progressors, while unaltered in HIV-1+LTNP. The expression of CXCR2 and CXCR4 and of CXCR4 and CCR5 were severely altered on PB mDC and pDC from HIV-1+ progressors, respectively. By contrast, both the expression of the chemokine receptors analysed and the numbers of CD16+ DC in HIV-1+ progressors were not different from AHV, while altered in HCV+/HIV-1- and HIV-1+LTNP. Furthermore, PB monocytes and DC from HIV-1+ progressors spontaneously produced inflammatory cytokines, in contrast with AHV. CONCLUSIONS: These results support the existence of a selective interaction between HIV-1 and both mDC and pDC, associated with HCV co-infection-independent spontaneous production of inflammatory cytokines, reflecting the occurrence of in vivo activation of the immune system, which might further contribute to the impaired DC functionality.
Authors: Viskam Wijewardana; Anthea L Bouwer; Kevin N Brown; Xiangdong Liu; Simon M Barratt-Boyes Journal: Immunology Date: 2014-10 Impact factor: 7.397
Authors: Paul E Makidon; Douglas M Smith; Jeffery V Groom Ii; Zhengyi Cao; Jeffery J Landers; James R Baker Journal: Comp Med Date: 2015-08 Impact factor: 0.982
Authors: Juan C Hernández; Mario Stevenson; Eicke Latz; Silvio Urcuqui-Inchima Journal: AIDS Res Hum Retroviruses Date: 2012-03-12 Impact factor: 2.205
Authors: Simona Fiorentini; Elena Riboldi; Fabio Facchetti; Manuela Avolio; Marco Fabbri; Giorgio Tosti; Pablo D Becker; Carlos A Guzman; Silvano Sozzani; Arnaldo Caruso Journal: Proc Natl Acad Sci U S A Date: 2008-02-29 Impact factor: 11.205
Authors: Andrew W Hardy; David R Graham; Gene M Shearer; Jean-Philippe Herbeuval Journal: Proc Natl Acad Sci U S A Date: 2007-10-23 Impact factor: 11.205
Authors: Clara Lehmann; Mark Lafferty; Alfredo Garzino-Demo; Norma Jung; Pia Hartmann; Gerd Fätkenheuer; Jeffrey S Wolf; Jan van Lunzen; Fabio Romerio Journal: PLoS One Date: 2010-06-14 Impact factor: 3.240
Authors: Vegard Tjomsland; Anna Spångeus; Per Sandström; Kurt Borch; Davorka Messmer; Marie Larsson Journal: PLoS One Date: 2010-10-15 Impact factor: 3.240